The LightPath® and 68Ga-RM2 in Breast Cancer Study
NCT03731026
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
80
Enrollment
INDUSTRY
Sponsor class
Conditions
Breast Cancer
Interventions
COMBINATION_PRODUCT:
LightPath® Imaging System and 68Ga-RM2
DRUG:
68Ga-RM2
Sponsor
Lightpoint Medical Limited